INHIBITION OF DENGUE VIRUS BY NOVEL, MODIFIED ANTISENSE OLIGONUCLEOTIDES

被引:31
|
作者
RAVIPRAKASH, K
LIU, K
MATTEUCCI, M
WAGNER, R
RIFFENBURGH, R
CARL, M
机构
[1] GILEAD SCI INC,FOSTER CITY,CA 94404
[2] USN,MED CTR,SAN DIEGO,CA 92134
关键词
D O I
10.1128/JVI.69.1.69-74.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Five different target regions along the length of the dengue virus type 2 genome were compared for inhibition of the virus following intracellular injection of the cognate antisense oligonucleotides and their analogs. Unmodified phosphodiester oligonucleotides as well as the corresponding phosphorothioate oligonucleotides were ineffective in bringing about a significant inhibition of the virus. Novel modified phosphorothioate oligonucleotides in which the C-5 atoms of uridines and cytidines were replaced by propynyl groups caused a significant inhibition of the virus. Antisense oligonucleotide directed against the target region near the translation initiation site of dengue virus RNA was the most effective, followed dy antisense oligonucleotide directed against a target in the 3' untranslated region of the virus RNA. It is suggested that the inhibitory effect of these novel modified oligonucleotides is due to their increased affinity for the target sequences and that they probably function via an RNase H cleavage of the oligonucleotide:RNA heteroduplex.
引用
收藏
页码:69 / 74
页数:6
相关论文
共 50 条
  • [31] RETROVIRAL INHIBITION BY ANTISENSE OLIGONUCLEOTIDES DETERMINED BY INTRACELLULAR STABILITY
    ROPERT, C
    OKRUSZEK, A
    COUVREUR, P
    MALVY, C
    ANTISENSE RESEARCH AND DEVELOPMENT, 1994, 4 (03): : 207 - 210
  • [32] Conjugated antisense oligonucleotides for inhibition of human cytomegalovirus in vitro
    Zhang, ZD
    Smith, JA
    Smyth, AP
    Eisenberg, W
    Nichols, A
    Pari, GS
    Tang, JY
    NUCLEOSIDES & NUCLEOTIDES, 1997, 16 (7-9): : 1169 - 1172
  • [33] Drug resistance inhibition in keukemic cells by antisense oligonucleotides
    Nadali, F.
    Pourfatollah, A. A.
    Alimoghaddam, K.
    VOX SANGUINIS, 2006, 91 : 90 - 90
  • [34] Alginate nanoparticles as a novel carrier for antisense oligonucleotides
    Ayme, I
    Vauthier, C
    Fattal, E
    Foulquier, M
    Couvreur, P
    FUTURE STRATEGIES FOR DRUG DELIVERY WITH PARTICULATE SYSTEMS, 1998, : 11 - 16
  • [35] INHIBITION OF REPLICATION OF HIV-1 BY ANTISENSE OLIGONUCLEOTIDES
    AGRAWAL, S
    GOODCHILD, J
    SARIN, P
    ZAMECNIK, PC
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (01) : 126 - 126
  • [36] Characterization of modified antisense oligonucleotides in Xenopus laevis embryos
    Lennox, KA
    Sabel, JL
    Johnson, MJ
    Moreira, BG
    Fletcher, CA
    Rose, SD
    Behlke, MA
    Laikhter, AL
    Walder, JA
    Dagle, JM
    OLIGONUCLEOTIDES, 2006, 16 (01) : 26 - 42
  • [37] THE DESIGN OF ANTISENSE OLIGONUCLEOTIDES AND INHIBITION OF GENE-EXPRESSION
    RAYNER, B
    IMBACH, JL
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (09): : 810 - 810
  • [38] An Overview of Sugar-Modified Oligonucleotides for Antisense Therapeutics
    Prakash, Thazha P.
    CHEMISTRY & BIODIVERSITY, 2011, 8 (09) : 1616 - 1641
  • [39] IN VIVO INHIBITION OF HBV ANTIGENEMIA AND VIREMIA BY ANTISENSE OLIGONUCLEOTIDES
    Billioud, G.
    Carrillo, M.
    Gao, D.
    Kim, A.
    McCaleb, M. L.
    Crosby, J.
    Hamatake, R.
    Hong, Z.
    Swayze, E.
    Wieland, S.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S50 - S50
  • [40] Development of a novel delivery system for antisense oligonucleotides
    Enneli, B.
    Salva, E.
    Akbuga, J.
    FEBS JOURNAL, 2006, 273 : 132 - 132